购物车
- 全部删除
- 您的购物车当前为空
Ginsenoside Rg5 是红参的主要成分,可阻断IGF-1与其受体的结合,IC50约为90 nM。它还通过抑制NF-κB p65的 DNA 结合活性来抑制COX-2的 mRNA 表达。它可促进血管生成和改善高血压,具有抗炎和治疗阿尔茨海默病的潜力。
为众多的药物研发团队赋能,
让新药发现更简单!
Ginsenoside Rg5 是红参的主要成分,可阻断IGF-1与其受体的结合,IC50约为90 nM。它还通过抑制NF-κB p65的 DNA 结合活性来抑制COX-2的 mRNA 表达。它可促进血管生成和改善高血压,具有抗炎和治疗阿尔茨海默病的潜力。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 935 | 现货 | |
5 mg | ¥ 2,320 | 现货 | |
10 mg | ¥ 3,730 | 现货 | |
25 mg | ¥ 5,890 | 现货 | |
50 mg | ¥ 8,290 | 现货 | |
100 mg | ¥ 11,200 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 3,150 | 现货 |
产品描述 | 1. Ginsenoside Rg5 could be a beneficial agent for the treatment of Alzheimer's disease. 2. Ginsenoside Rg5 suppresses LPS-induced nitric oxide (NO) production and proinflammatory TNF-α secretion. 3. Ginsenoside Rg5 can ameliorate lung inflammation possibly by inhibiting the binding of LPS to toll-like receptor (TLR)-4 on macrophages. 4. Ginsenoside Rg5 plays a novel role as an IGF-1R agonist, promoting therapeutic angiogenesis and improving hypertension without adverse effects in the vasculature. 5. Ginsenoside Rg5 blocks cell cycle of SK-HEP-1 cells at the Gl/S transition phase by down-regulating cyclin E-dependent kinase activity and that the down-regulation of cyclin E-dependent kinase activity is caused mainly by induced CDK2 inhibitor, p21Cip/WAF1 and decreased levels of cyclin E. |
靶点活性 | IGF-1:90 nM |
别名 | 人参皂苷Rg5, 人参皂甙 Rg5 |
分子量 | 767 |
分子式 | C42H70O12 |
CAS No. | 186763-78-0 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 60 mg/mL (78.23 mM) | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
中药材名称 | 中药材拉丁名 | 性 | 味 | 归经 |
---|---|---|---|---|
人参芦 | Panax ginseng C. A. Mey. | 温 | 甘, 微苦 | 胃, 脾, 肺 |
中成药名称 | 处方组成 | 中成药类型 |
---|---|---|
补气升提片 | 人参芦,党参,黄芪,白术,广升麻,阿胶,甘草(炙) | 扶正药 |
方剂名称 | 处方组成 | 剂型 | 处方来源 |
---|---|---|---|
取吐散 | 人参芦,柴胡,大黄,茵陈,鳖甲 | 散剂 | 《圣惠》卷十七。 |
参芦汤 | 人参芦 | 汤剂 | 方出《格致余论》,名见《本草纲目》卷十二。 |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.